Condition

Anaplastic Astrocytoma

ClinicalTrials.gov condition label

Clinical trials4

Recruiting0

Common interventions8

Lead sponsors shown4

Clinical trials

4 shown

Ga-68 Prostate Specific Membrane Antigen PET/CT in GliomasNCT06241391 · 2024-02-01

UNKNOWN

Pediatric Long-Term Follow-up and Rollover StudyNCT03975829 · 2019-11-04

ACTIVE_NOT_RECRUITING

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsNCT01522820 · 2012-03-01

COMPLETED

Expanded Access to ANG1005 for Individual PatientsNCT02755987

NO_LONGER_AVAILABLE

Common interventions

ANG1005DRUG1dabrafenibDRUG1DEC-205/NY-ESO-1 Fusion Protein CDX-1401BIOLOGICAL1Laboratory Biomarker AnalysisOTHER1Pharmacological StudyOTHER1PSMA PET-CTDIAGNOSTIC_TEST1SirolimusDRUG1trametinibDRUG1

Leading sponsors

All India Institute of Medical Sciences, Bhubaneswar1Angiochem Inc1Novartis Pharmaceuticals1Roswell Park Cancer Institute1

Trial status mix

ACTIVE_NOT_RECRUITING1

COMPLETED1

NO_LONGER_AVAILABLE1

UNKNOWN1

Phase mix

NA1

PHASE11

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.